V940 2025

Get Form
v940 Preview on Page 1

Here's how it works

01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

The best way to modify V940 online

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2

With DocHub, making changes to your documentation takes only a few simple clicks. Make these fast steps to modify the PDF V940 online for free:

  1. Sign up and log in to your account. Sign in to the editor using your credentials or click on Create free account to evaluate the tool’s capabilities.
  2. Add the V940 for redacting. Click the New Document button above, then drag and drop the sample to the upload area, import it from the cloud, or via a link.
  3. Change your file. Make any changes required: insert text and photos to your V940, underline information that matters, remove sections of content and substitute them with new ones, and insert icons, checkmarks, and areas for filling out.
  4. Complete redacting the form. Save the modified document on your device, export it to the cloud, print it right from the editor, or share it with all the parties involved.

Our editor is very user-friendly and efficient. Try it out now!

See more v940 versions

We've got more versions of the v940 form. Select the right v940 version from the list and start editing it straight away!
Versions Form popularity Fillable & printable
2019 4.8 Satisfied (181 Votes)
2019 4.2 Satisfied (118 Votes)
2019 4.4 Satisfied (275 Votes)
2014 4.3 Satisfied (52 Votes)
2007 4 Satisfied (58 Votes)
be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
About mRNA-4157 (V940) Upon administration into the body, the algorithmically derived and RNA-encoded neoantigen sequences are endogenously translated and undergo natural cellular antigen processing and presentation, a key step in adaptive immunity.
The most common adverse events attributed to mRNA-4157 (V940) in combination with KEYTRUDA were fatigue (60.6%), injection site pain (56.7%), and chills (49.0%). The majority of the adverse events attributed to mRNA-4157 (V940) were Grade 1-2, with fatigue being the most common Grade 3 event and no Grade 4-5 events.
mRNA-4157/V940 is designed to stimulate an immune response by generating specific T cell responses based on the unique mutational signature of a patients tumor. KEYTRUDA is an immunotherapy that works by increasing the ability of the bodys immune system to help detect and fight tumor cells.
After vaccination, the mRNA will enter the muscle cells. Once inside, they use the cells machinery to produce a harmless piece of what is called the spike protein. The spike protein is found on the surface of the virus that causes COVID-19.
mRNA-4157/V940 is an mRNA based cancer vaccine. When administered, it will produce one of several dozen possible abnormal proteins commonly found in cancerous tissues. The production of those proteins is intended to invoke an immune response.
be ready to get more

Complete this form in 5 minutes or less

Get form

People also ask

Safety, tolerability, and immunogenicity were assessed. All patients experienced 1 treatment-emergent adverse event; there were no grade 4/5 adverse events or dose-limiting toxicities. mRNA-4157 alone induced consistent de novo and strengthened preexisting T-cell responses to targeted neoantigens.
Fatal adverse reactions occurred in 8% of patients who received KEYTRUDA including infection (2.3%) and thromboembolism (1.3%). KEYTRUDA was permanently discontinued due to adverse reactions in 15% of patients.

Related links